Biochemical Markers in Covid-19 Patients in Tripoli, Libya; A Retrospective Study

Ahmed  Abired; Zeineb  Alsharef; Takwa Miftah; Gofran Enwere

doi:10.54361/Ljmr18-1.21

Authors

V Department of physiotherapy, Medical Sciences and Technologies Collage, Tripoli, Libya. Author
Zeineb Alsharef Department of basic nursing, faculty of Nursing, University of Tripoli, Tripoli, Libya. Author
Takwa Miftah Department of pharmaceutical sciences, University of Tripoli Alahlia, Janzur, Libya. Author
Gofran Enwere Department of pharmaceutical sciences, University of Tripoli Alahlia, Janzur, Libya. Author

DOI:

https://doi.org/10.54361/Ljmr18-1.21

Keywords:

Covid, Biochemica, parameters, Retrospective, Tripoli,, Libya

Abstract

Covid 19 can cause fatal pneumonia and serious complications. In the course of the disease the levels of different biochemical parameters increased and these parameters provide important information about the prognosis of the disease. The aim of this study was to investigate these biomarkers and to evaluate the relationship between biochemical parameters and length of stay in Covid 19 patients. A retrospective study was conducted from October 2020 to December 2021. A total of 156 Covid 19 patients hospitalized in Meitiga Military hospital were included. The demographic characteristics, length of stay, and

biochemical parameters of the patients were scanned from the hospital's database and patient files and recorded. Patients were grouped according to the length of stay; 1st group: after 3 to 5 days, 2nd group: from 8 to 12 days, and 3rd group: after 13 days and more. Most of admitted cases were males, the majority of the participants were in age above 65 years old. CRP, FER, LDH, and D-dimer were gradually increased to the maximum mean; 131.4±67, 1052.3±710.1, 586±128.9, and 1196.2±409.1, respectively after 8 to 12 days and return to normal range after 13 days. To conclude, there is a positive correlation between the levels of these biomarkers and the prolongation of hospitalization in COVID-19 patients and these parameters can be associated with the severity disease.

References

Higgins, J. P., et al., (2003). Measuring inconsistency in meta-analyses. Bmj, 327(7414), 557-560. DOI: https://doi.org/10.1136/bmj.327.7414.557

Lippi, G., & Henry, B. M. (2020). Chronic obstructive pulmonary disease is associated with severe coronavirus disease 2019 (COVID-19). Respiratory medicine, 167, 105941. DOI: https://doi.org/10.1016/j.rmed.2020.105941

Guan, W. J., et al., (2020). Clinical characteristics of coronavirus disease 2019 in China. New England journal of medicine, 382(18), 1708-1720. DOI: https://doi.org/10.1056/NEJMoa2002032

Xiang, J., et al., (2020). Potential biochemical markers to identify severe cases among COVID-19 patients. MedRxiv, 2020-03. DOI: https://doi.org/10.1101/2020.03.19.20034447

Shereen, M. A., et al., (2020). COVID-19 infection: Emergence, transmission, and characteristics of human coronaviruses. Journal of advanced research, 24, 91-98. DOI: https://doi.org/10.1016/j.jare.2020.03.005

Asghar, M. S., et al., (2021). Correlation of refractory hypoxemia with biochemical markers and clinical outcomes of COVID-19 patients in a developing country: A retrospective observational study: Running head: Predictors of hypoxemia in COVID-19. Journal of Community Hospital Internal Medicine Perspectives, 11(1), 9-16. DOI: https://doi.org/10.1080/20009666.2020.1835214

World Health Organization. WHO Coronavirus Disease (COVID-19) Dashboard. Available from: https://COVID19.who.int/ . Accessed 2023 (Sep 01).

Wang, D., et al., (2020). Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China. jama, 323(11), 1061-1069. DOI: https://doi.org/10.1001/jama.2020.1585

Huang, C., et al., (2020). Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The lancet, 395(10223), 497-506. DOI: https://doi.org/10.1016/S0140-6736(20)30183-5

Palaiodimos, L., et al., (2020). Severe obesity, increasing age and male sex are independently associated with worse in-hospital outcomes, and higher in-hospital mortality, in a cohort of patients with COVID-19 in the Bronx, New York. Metabolism, 108, 154262. DOI: https://doi.org/10.1016/j.metabol.2020.154262

Cowling, B. J., & Aiello, A. E. (2020). Public health measures to slow community spread of coronavirus disease 2019. The Journal of infectious diseases, 221(11), 1749-1751. DOI: https://doi.org/10.1093/infdis/jiaa123

Liu, X., Zhang, R., & He, G. (2020). Hematological findings in coronavirus disease 2019: indications of progression of disease. Annals of hematology, 99, 1421-1428. DOI: https://doi.org/10.1007/s00277-020-04103-5

Sato, H., Tsubosa, Y., & Kawano, T. (2012). Correlation between the pretherapeutic neutrophil to lymphocyte ratio and the pathologic response to neoadjuvant chemotherapy in patients with advanced esophageal cancer. World journal of surgery, 36, 617-622. DOI: https://doi.org/10.1007/s00268-011-1411-1

Martins, E. C., et al., (2019). Neutrophil-lymphocyte ratio in the early diagnosis of sepsis in an intensive care unit: a case-control study. Revista Brasileira de terapia intensiva, 31, 64-70. DOI: https://doi.org/10.5935/0103-507X.20190010

Ciaccio, M., & Agnello, L. (2020). Biochemical biomarkers alterations in Coronavirus Disease 2019 (COVID-19). Diagnosis, 7(4), 365-372. DOI: https://doi.org/10.1515/dx-2020-0057

Peiró, Ó. M., et al., (2021). Biomarkers and short-term prognosis in COVID-19. Biomarkers, 26(2), 119-126. DOI: https://doi.org/10.1080/1354750X.2021.1874052

Anani, M., et al., (2022). Evaluation of blood and biochemical parameters of COVID-19 patients in Suez Canal University Hospital; A retrospective study. The Journal of Infection in Developing Countries, 16(04), 592-599. DOI: https://doi.org/10.3855/jidc.14591

Capraru, I. D., et al., (2023). COVID-19 Biomarkers Comparison: Children, Adults and Elders. Medicina, 59(5), 877. DOI: https://doi.org/10.3390/medicina59050877

Yuan, X., et al., (2020). Changes of hematological and immunological parameters in COVID-19 patients. International journal of hematology, 112, 553-559. DOI: https://doi.org/10.1007/s12185-020-02930-w

Delen, L. A., ERDOĞAN, E., & YAŞAR, Ş. (2021). The Risk Factors Affecting Length of Stay and Mortality in Covid 19 Patients: Laboratory Parameters, Comorbidities, and Demographic Characteristics. Konuralp Medical Journal, 13(S1), 474-478. DOI: https://doi.org/10.18521/ktd.899368

Wong, R. S., et al., (2003). Haematological manifestations in patients with severe acute respiratory syndrome: retrospective analysis. Bmj, 326(7403), 1358-1362. DOI: https://doi.org/10.1136/bmj.326.7403.1358

HUSSEIN, S. Z. (2022). The relationship of some biochemical markers with inflammatory prognosis in COVID-19 patients. Modern Medicine, 29(3). DOI: https://doi.org/10.31689/rmm.2022.29.3.241

Chen, W., et al., (2020). Plasma CRP level is positively associated with the severity of COVID-19. Annals of clinical microbiology and antimicrobials, 19(1), 1-7. DOI: https://doi.org/10.1186/s12941-020-00362-2

Yuan, J., et al., (2020). The correlation between viral clearance and biochemical outcomes of 94 COVID-19 infected discharged patients. Inflammation Research, 69, 599-606. DOI: https://doi.org/10.1007/s00011-020-01342-0

Ji, D., et al., (2020). Clinical characteristics predicting progression of COVID-19. DOI: https://doi.org/10.2139/ssrn.3539674

Liu, J., et al., (2020). Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients. EBioMedicine, 55. DOI: https://doi.org/10.1016/j.ebiom.2020.102763

Deng, X., et al., (2020). Blood biochemical characteristics of patients with coronavirus disease 2019 (COVID-19): a systemic review and meta-analysis. Clinical Chemistry and Laboratory Medicine (CCLM), 58(8), 1172-1181. DOI: https://doi.org/10.1515/cclm-2020-0338

Danese, E., & Montagnana, M. (2016). An historical approach to the diagnostic biomarkers of acute coronary syndrome. Annals of translational medicine, 4(10). DOI: https://doi.org/10.21037/atm.2016.05.19

Martha, J. W., Wibowo, A., & Pranata, R. (2022). Prognostic value of elevated lactate dehydrogenase in patients with COVID-19: a systematic review and meta-analysis. Postgraduate medical journal, 98(1160), 422-427. DOI: https://doi.org/10.1136/postgradmedj-2020-139542

Szarpak, L., et al., (2021). Lactate dehydrogenase level as a COVID-19 severity marker. Am J Emerg Med, 45(45), 638-9. DOI: https://doi.org/10.1016/j.ajem.2020.11.025

Tang, N., et al., (2020). Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. Journal of thrombosis and haemostasis, 18(5), 1094-1099. DOI: https://doi.org/10.1111/jth.14817

Aboughdir, et al., (2020). Prognostic value of cardiovascular biomarkers in COVID-19: a review. Viruses, 12(5), 527. DOI: https://doi.org/10.3390/v12050527

Zhang, L., et al., (2020). D‐dimer levels on admission to predict in‐hospital mortality in patients with Covid‐19. Journal of thrombosis and haemostasis, 18(6), 1324-1329. DOI: https://doi.org/10.1111/jth.14859

Ye, W., et al., (2020). Dynamic changes of D-dimer and neutrophil-lymphocyte count ratio as prognostic biomarkers in COVID-19. Respiratory research, 21(1), 1-7. DOI: https://doi.org/10.1186/s12931-020-01428-7